---
title: "Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287908379.md"
description: "In Bad Homburg, Germany, on May 28, 2026, Fresenius Medical Care (FME), a global leader in renal disease products and services, revealed the initiation of the initial phase of its share buyback scheme, encompassing roughly EUR 1 billion."
datetime: "2026-05-28T11:02:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287908379.md)
  - [en](https://longbridge.com/en/news/287908379.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287908379.md)
---

# Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million

In Bad Homburg, Germany, on May 28, 2026, Fresenius Medical Care (FME), a global leader in renal disease products and services, revealed the initiation of the initial phase of its share buyback scheme, encompassing roughly EUR 1 billion.

### Related Stocks

- [FMS.US](https://longbridge.com/en/quote/FMS.US.md)
- [FME.DE](https://longbridge.com/en/quote/FME.DE.md)

## Related News & Research

- [Fiduciary Management Inc. WI Sells 495,419 Shares of Fresenius Medical Care AG & Co. KGaA $FMS](https://longbridge.com/en/news/288952590.md)
- [Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis | FMS Stock News](https://longbridge.com/en/news/288572081.md)
- [Weekly share repurchase program transaction details | SBFFF Stock News](https://longbridge.com/en/news/288608163.md)
- [ERA 2026: HighTide Therapeutics Presents New Findings Supporting HTD1801's Renoprotective Potential in Oral Presentation](https://longbridge.com/en/news/288805506.md)
- [09:42 ETNational Kidney Foundation and U.S. Pharmacy Organizations Call for Transition to Race-Agnostic eGFR in Medication Decision-Making](https://longbridge.com/en/news/289065527.md)